Comparison Overview

MAD Talks

VS

U. S. Pharmacist

MAD Talks

Dubai Media City, Building No. 5, Dubai, AE
Last Update: 2025-11-21
Between 750 and 799

MAD Talks is a storytelling and content platform that brings you access to stories of aspiring entrepreneurs, business leaders and inspiring thought leaders. We are MAD because we want to Make A Difference by empowering leaders of the next generation to harness the momentum of our increasingly fast and innovative world. We bring our network of top business leaders, rising entrepreneurs and expert mentors to our audience through community events and masterclasses. This is the opportunity to speak with your voice. Inspire and be inspired.

NAICS: 511
NAICS Definition: Publishing Industries (except Internet)
Employees: 4
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

U. S. Pharmacist

160 Chubb Ave, Lyndhurst, New Jersey, 07071, US
Last Update: 2025-11-26
Between 750 and 799

U.S. Pharmacist is a peer-reviewed clinical journal for Pharmacists, committed to providing pharmacists with the highest quality clinical information. Our journal and digital programs deliver pharmacists with “need to know” information, relevant to the clinical aspects of today’s pharmacy practice, with the goal of improving patient care. U.S. Pharmacist original pharmacist authored articles focus on providing practical information for managing patients’ drug therapies, initiating preventive care, and improving treatment outcomes. Features and departments address Rx and OTC products, alternative and complementary therapies, compounding, acute patient care, long-term patient care, and outpatient pharmacy care. U.S. Pharmacist provides pharmacists education and clinical content needed to provide patient care, with Continuing Education featured in every issue. Visit www.uspharmacist.com for digital editions, CPE, Patient Teaching Aids and more!

NAICS: 511
NAICS Definition:
Employees: 7
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/mad-talks.jpeg
MAD Talks
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/u-s-pharmacist.jpeg
U. S. Pharmacist
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
MAD Talks
100%
Compliance Rate
0/4 Standards Verified
U. S. Pharmacist
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for MAD Talks in 2025.

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for U. S. Pharmacist in 2025.

Incident History — MAD Talks (X = Date, Y = Severity)

MAD Talks cyber incidents detection timeline including parent company and subsidiaries

Incident History — U. S. Pharmacist (X = Date, Y = Severity)

U. S. Pharmacist cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/mad-talks.jpeg
MAD Talks
Incidents

No Incident

https://images.rankiteo.com/companyimages/u-s-pharmacist.jpeg
U. S. Pharmacist
Incidents

No Incident

FAQ

MAD Talks company demonstrates a stronger AI Cybersecurity Score compared to U. S. Pharmacist company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, U. S. Pharmacist company has disclosed a higher number of cyber incidents compared to MAD Talks company.

In the current year, U. S. Pharmacist company and MAD Talks company have not reported any cyber incidents.

Neither U. S. Pharmacist company nor MAD Talks company has reported experiencing a ransomware attack publicly.

Neither U. S. Pharmacist company nor MAD Talks company has reported experiencing a data breach publicly.

Neither U. S. Pharmacist company nor MAD Talks company has reported experiencing targeted cyberattacks publicly.

Neither MAD Talks company nor U. S. Pharmacist company has reported experiencing or disclosing vulnerabilities publicly.

Neither MAD Talks nor U. S. Pharmacist holds any compliance certifications.

Neither company holds any compliance certifications.

Neither MAD Talks company nor U. S. Pharmacist company has publicly disclosed detailed information about the number of their subsidiaries.

U. S. Pharmacist company employs more people globally than MAD Talks company, reflecting its scale as a Book and Periodical Publishing.

Neither MAD Talks nor U. S. Pharmacist holds SOC 2 Type 1 certification.

Neither MAD Talks nor U. S. Pharmacist holds SOC 2 Type 2 certification.

Neither MAD Talks nor U. S. Pharmacist holds ISO 27001 certification.

Neither MAD Talks nor U. S. Pharmacist holds PCI DSS certification.

Neither MAD Talks nor U. S. Pharmacist holds HIPAA certification.

Neither MAD Talks nor U. S. Pharmacist holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.

Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).

Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint

Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description

Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.

Description

Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.